PRICING AND REIMBURSEMENT POLICY UPDATES IN ASIA

被引:1
|
作者
Paranjoy, S. [1 ]
Kaushik, P. [1 ]
Kaur, S. [1 ]
Sharma, S. [1 ]
Sehgal, M. [1 ]
机构
[1] PAREXEL Int, HERON Commercializat, Chandigarh, India
关键词
D O I
10.1016/j.jval.2014.08.418
中图分类号
F [经济];
学科分类号
02 ;
摘要
PHP17
引用
收藏
页码:A788 / A788
页数:1
相关论文
共 50 条
  • [1] The 1996 pricing and reimbursement policy in the Netherlands
    deVos, CM
    [J]. PHARMACOECONOMICS, 1996, 10 : 75 - 80
  • [2] On the welfare analysis of external reference pricing and reimbursement policy
    Dong, Van-Chung
    Lin, Yan-Shu
    Shih, Pei-Cyuan
    [J]. ESTUDIOS DE ECONOMIA, 2023, 50 (01): : 133 - 158
  • [3] DRUG POLICY IN SLOVAKIA: IMPACT OF PRICING AND REIMBURSEMENT REFORMS
    Glatz, P.
    Ilavska, A.
    Hloska, A.
    Filko, M.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A95 - A95
  • [4] EQUITY IN PHARMACEUTICAL PRICING AND REIMBURSEMENT: CROSSING THE INCOME DIVIDE IN ASIA PACIFIC
    Daems, R. P.
    Maes, E.
    Glaetzer, C.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A616 - A616
  • [5] ASSESSMENT OF THE ORPHAN DRUG PRICING AND REIMBURSEMENT LANDSCAPE IN THE ASIA PACIFIC REGION
    Mukku, S. R.
    Pang, F.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A537 - A537
  • [6] EVIDENCE REQUIREMENTS FOR PRICING AND REIMBURSEMENT DECISION MAKING FOR ORPHAN DRUGS IN ASIA
    Tan, S.
    Dummett, H.
    Kirpekar, S.
    Guan, Q.
    Priest, V. L.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A621 - A622
  • [7] Reimbursement: Resources and Updates
    Goodwin, J.
    [J]. MEDICAL PHYSICS, 2011, 38 (06)
  • [8] Stakeholder preferences about policy objectives and measures of pharmaceutical pricing and reimbursement
    Vogler, Sabine
    Zimmermann, Nina
    Habimana, Katharina
    [J]. HEALTH POLICY AND TECHNOLOGY, 2016, 5 (03) : 213 - 225
  • [9] PRICING UPDATES
    MERRIMAN, JB
    [J]. LIBRARY ACQUISITIONS-PRACTICE AND THEORY, 1990, 14 (03): : 295 - 296
  • [10] THE PRICING AND REIMBURSEMENT OF PHARMACEUTICALS
    TOWSE, A
    [J]. PHARMACOECONOMICS, 1994, 6 : 36 - 38